Findings

What do systematic reviews say?

807 questions · 849 findings · 68 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 236 · 27.8%GRADE not reported 50 · 5.9%Very low 266 · 31.3%Low 168 · 19.8%Moderate 104 · 12.2%High 25 · 2.9%

CBT vs no treatment

Vertigo (global score) at < 3 months · adults with vestibular migraine

1 finding from 1 review

Non‐pharmacological interventions for prophylaxis of vestibular migraine 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

CBT vs no treatment

Serious adverse events · adults with vestibular migraine

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for prophylaxis of vestibular migraine 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vestibular rehabilitation vs no treatment

Improvement in vertigo · adults with vestibular migraine

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for prophylaxis of vestibular migraine 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vestibular rehabilitation vs no treatment

Change in vertigo · adults with vestibular migraine

1 finding from 1 review

Non‐pharmacological interventions for prophylaxis of vestibular migraine 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

Vestibular rehabilitation vs placebo or no treatment

Serious adverse events · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vestibular rehabilitation vs placebo or no treatment

CI: Confidence interval · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Talking therapies or stress management vs placebo or no treatment

Improvement in vertigo · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Talking therapies or stress management vs placebo or no treatment

Change in vertigo · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Talking therapies or stress management vs placebo or no treatment

Serious adverse events · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Talking therapies or stress management vs placebo or no treatment

CI: Confidence interval · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vestibular rehabilitation vs placebo or no treatment

Improvement in vertigo · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vestibular rehabilitation vs placebo or no treatment

Change in vertigo · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Physical activity vs Pharmacological therapy

IBS symptoms · people with IBS

1 finding from 1 review

Physical activity for treatment of irritable bowel syndrome 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 21 participants
Very low

Metformin vs placebo or no treatment

Weight: clinically important change in weight (kg) · people with schizophrenia with antipsychotic‐induced weight gain

1 finding from 1 review

Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Metformin vs placebo or no treatment

Change in weight (kg) · people with schizophrenia with antipsychotic‐induced weight gain

1 finding from 1 review

Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 131 participants
Low

Topiramate vs placebo or no treatment

Weight: clinically important change in weight (kg) · people with schizophrenia with antipsychotic‐induced weight gain

1 finding from 1 review

Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Topiramate vs placebo or no treatment

Change in weight (kg) · people with schizophrenia with antipsychotic‐induced weight gain

1 finding from 1 review

Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 168 participants
Very low

Topiramate vs placebo or no treatment

Weight: clinically important change in BMI (kg/m2) · people with schizophrenia with antipsychotic‐induced weight gain

1 finding from 1 review

Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Topiramate vs placebo or no treatment

Change in BMI · people with schizophrenia with antipsychotic‐induced weight gain

1 finding from 1 review

Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 120 participants
Very low

Topiramate vs placebo or no treatment

Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain

Topiramate showed no clear difference in leaving the study early: for any reason compared with placebo or no treatment (low certainty).

1 finding from 1 review

Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes only
RR 1.09 [0.85, 1.41]
2 studies · 132 participants
Low